- Home
- BANL vs BOLD Comparison
BANL vs BOLD Comparison
Compare BANL & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANL
- BOLD
- Stock Information
- Founded
- BANL 2015
- BOLD 2018
- Country
- BANL Malaysia
- BOLD United States
- Employees
- BANL N/A
- BOLD N/A
- Industry
- BANL Oil Refining/Marketing
- BOLD
- Sector
- BANL Energy
- BOLD
- Exchange
- BANL Nasdaq
- BOLD Nasdaq
- Market Cap
- BANL 25.3M
- BOLD 24.4M
- IPO Year
- BANL 2023
- BOLD 2024
- Fundamental
- Price
- BANL $0.74
- BOLD $1.18
- Analyst Decision
- BANL
- BOLD Buy
- Analyst Count
- BANL 0
- BOLD 3
- Target Price
- BANL N/A
- BOLD $4.00
- AVG Volume (30 Days)
- BANL 187.7K
- BOLD 105.5K
- Earning Date
- BANL 09-11-2025
- BOLD 08-11-2025
- Dividend Yield
- BANL N/A
- BOLD N/A
- EPS Growth
- BANL N/A
- BOLD N/A
- EPS
- BANL N/A
- BOLD N/A
- Revenue
- BANL $592,517,545.00
- BOLD N/A
- Revenue This Year
- BANL N/A
- BOLD N/A
- Revenue Next Year
- BANL N/A
- BOLD N/A
- P/E Ratio
- BANL N/A
- BOLD N/A
- Revenue Growth
- BANL 35.93
- BOLD N/A
- 52 Week Low
- BANL $0.55
- BOLD $1.00
- 52 Week High
- BANL $1.35
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- BANL 41.00
- BOLD N/A
- Support Level
- BANL $0.74
- BOLD N/A
- Resistance Level
- BANL $0.84
- BOLD N/A
- Average True Range (ATR)
- BANL 0.06
- BOLD 0.00
- MACD
- BANL -0.00
- BOLD 0.00
- Stochastic Oscillator
- BANL 16.41
- BOLD 0.00
About BANL CBL International Limited
CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.